ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019

SAN DIEGO–(BUSINESS WIRE)–ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019. Fourth Quarter 2019 Highlights Revenue increased 13% to $705.0 million; up 15% on a constant currency basis Gross margin expanded 120 bps to 59.3% Net operating profit decreased 18%; non-GAAP operating profit up 18% GAAP diluted earnings per share of $0.48; non-GAAP diluted earnings per share of $0.95 Quarterly dividend increased b